An oriP expression vector containing the HIV-1 Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells
- 102 Downloads
A mammalian gene expression vector based on cytomegalovirus (CMV)enhancer/promoter (CMVe/p) for the regulation of gene expression was further optimized by adding oriP elements derived from Epstein-Barr virus (EBV) and the Tat/TAR transactivation axisfrom human immunodeficiency virus type 1 (HIV-1). Using the Tat/TAR-oriP expression vector, a transient transfection system was optimized for an extended culture period to produce large amounts of secreted IL-2SA (an IL-2 mutein) in HKB11 cells. We observed a 4-fold increase in IL-2SA expression in cells transfected with vectors containing the HIV-1 transactivation axis (Tat/TAR) or oriP elements alone when compared to cells transfected with the control vector having a CMVe/p. Cells transfected with expression vectors equipped with both oriP and Tat/TAR showed an 18-fold increase in IL-2SA expression. This transient transfection system maintained high secretion of IL-2SA for a period of 10-day with no appreciable loss in expression. We demonstrate that during this 10-day culture period, it was possible to produce 1–100 mg of proteins using 500 μg of plasmid DNA.
Unable to display preview. Download preview PDF.
- Cho MS (2000) Human hybrid host cell for mammalian gene expression. United States Patent No. 6,136,599.Google Scholar
- Haseltine WA, Rosen CA, Sordroski JG, Wong-Staal F and Arya SK (1998) Nucleic acid encoding HIV-1 tat protein. United State Patent No. 5,801,056.Google Scholar
- Rabson M, Heston L, and Miller G (1983) Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. Proc Natl Acad Sci USA 87: 3660–3664.Google Scholar
- Sugden WM (1987) Recombinant vector and eukaryotic host transformed thereby. United State Patent No. 4,686,186.Google Scholar